MOMA Therapeutics, a clinical-stage precision medicine company targeting dynamic proteins like molecular machines through small molecules, needed a robust data management platform early on to handle their complex research. With 400 identified proteins poised for extensive genome experimentation in target discovery, they required tools to make analyses accessible to non-computational scientists, integrate chemical and biological data seamlessly, and enable feedback loops for iterative refinement. Revvity Signals software helped by providing an intuitive platform that centralized diverse datasets, simplified advanced analytics, fostered collaboration between chemists and biologists, and accelerated the path from protein identification to actionable drug discovery insights.

Join for free to read